Drug Shortage Report for TRETTEN
Report ID | 229680 |
Drug Identification Number | 02389975 |
Brand name | TRETTEN |
Common or Proper name | TRETTEN |
Company Name | NOVO NORDISK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | CATRIDECACOG |
Strength(s) | 2500UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 1 |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2024-06-05 |
Actual start date | 2024-06-05 |
Estimated end date | 2024-06-10 |
Actual end date | 2024-06-10 |
Shortage status | Resolved |
Updated date | 2024-06-11 |
Company comments | delay in release |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 101-2476 ARGENTIA ROAD MISSISSAUGA, ONTARIO CANADA L5N 6M1 |
Company contact information | 1 800 465 4334 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-06-11 | English | Compare |
v7 | 2024-06-10 | French | Compare |
v6 | 2024-06-10 | English | Compare |
v5 | 2024-06-06 | English | Compare |
v4 | 2024-06-05 | French | Compare |
v3 | 2024-06-05 | English | Compare |
v2 | 2024-06-05 | French | Compare |
v1 | 2024-06-05 | English | Compare |
Showing 1 to 8 of 8